Orthofix Medical Inc.

13.46
0.32 (2.44%)
At close: Apr 23, 2025, 3:59 PM
13.42
-0.33%
After-hours: Apr 23, 2025, 05:30 PM EDT

Orthofix Medical Statistics

Share Statistics

Orthofix Medical has 39.02M shares outstanding. The number of shares has increased by 3.98% in one year.

Shares Outstanding 39.02M
Shares Change (YoY) 3.98%
Shares Change (QoQ) 2.12%
Owned by Institutions (%) 85.86%
Shares Floating 37.33M
Failed to Deliver (FTD) Shares 883
FTD / Avg. Volume 0.42%

Short Selling Information

The latest short interest is 707.85K, so 1.81% of the outstanding shares have been sold short.

Short Interest 707.85K
Short % of Shares Out 1.81%
Short % of Float 1.86%
Short Ratio (days to cover) 3.17

Valuation Ratios

The PE ratio is -5.37 and the forward PE ratio is -19. Orthofix Medical's PEG ratio is 0.27.

PE Ratio -5.37
Forward PE -19
PS Ratio 0.83
Forward PS 0.5
PB Ratio 1.32
P/FCF Ratio -73.28
PEG Ratio 0.27
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Orthofix Medical.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.36.

Current Ratio 2.57
Quick Ratio 1.45
Debt / Equity 0.36
Debt / EBITDA -9.85
Debt / FCF -19.77
Interest Coverage -2.86

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $494.73K
Profits Per Employee $-76.66K
Employee Count 1,616
Asset Turnover 0.89
Inventory Turnover 1.34

Taxes

Income Tax 2.12M
Effective Tax Rate -1.71%

Stock Price Statistics

The stock price has increased by -0.38% in the last 52 weeks. The beta is 1, so Orthofix Medical's price volatility has been higher than the market average.

Beta 1
52-Week Price Change -0.38%
50-Day Moving Average 16.29
200-Day Moving Average 16.82
Relative Strength Index (RSI) 28.76
Average Volume (20 Days) 208.89K

Income Statement

In the last 12 months, Orthofix Medical had revenue of 799.49M and earned -123.88M in profits. Earnings per share was -3.3.

Revenue 799.49M
Gross Profit 545.88M
Operating Income -84.62M
Net Income -123.88M
EBITDA -18.24M
EBIT -94.24M
Earnings Per Share (EPS) -3.3
Full Income Statement

Balance Sheet

The company has 83.24M in cash and 179.63M in debt, giving a net cash position of -96.39M.

Cash & Cash Equivalents 83.24M
Total Debt 179.63M
Net Cash -96.39M
Retained Earnings -276.14M
Total Assets 893.29M
Working Capital 264.66M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 25.79M and capital expenditures -34.88M, giving a free cash flow of -9.09M.

Operating Cash Flow 25.79M
Capital Expenditures -34.88M
Free Cash Flow -9.09M
FCF Per Share -0.24
Full Cash Flow Statement

Margins

Gross margin is 68.28%, with operating and profit margins of -10.58% and -15.49%.

Gross Margin 68.28%
Operating Margin -10.58%
Pretax Margin -15.49%
Profit Margin -15.49%
EBITDA Margin -2.28%
EBIT Margin -10.58%
FCF Margin -1.14%

Dividends & Yields

OFIX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for OFIX is $24, which is 82.2% higher than the current price. The consensus rating is "Buy".

Price Target $24
Price Target Difference 82.2%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Scores

Altman Z-Score 1.25
Piotroski F-Score 5